Cargando…
EO9: relationship between DT-diaphorase levels and response in vitro and in vivo.
EO9 [3-hydroxy-5-aziridinyl-1-methyl-2(1H-indole-4,7-dione)-prop-beta-en- alpha-ol] was selected for clinical trial in Europe because of its preclinical profile but also because of its distinct mechanism of bioactivation. Several studies have shown that cells rich in DT-diaphorase may be particularl...
Autores principales: | Collard, J., Matthew, A. M., Double, J. A., Bibby, M. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033862/ https://www.ncbi.nlm.nih.gov/pubmed/7779711 |
Ejemplares similares
-
DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
por: Plumb, J. A., et al.
Publicado: (1994) -
Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.
por: Maliepaard, M., et al.
Publicado: (1995) -
Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.
por: Kuehl, B. L., et al.
Publicado: (1995) -
Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent EO9.
por: Bailey, S. M., et al.
Publicado: (1997) -
Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐Diaphorase
por: Mikami, Koji, et al.
Publicado: (1998)